• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human GA-binding protein subunit beta-2 (GABPB2)

ACP13629

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13629 Target NameGABPB2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-448Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8TAK5
Background Information
  • Uniprot Id

    Q8TAK5

  • Target Species

    Human

  • Target Name

    GABPB2

  • Target Full Name

    GA-binding protein subunit beta-2

  • Target Function

    May function as transcription factor capable of interacting with purine rich repeats (GA repeats).

  • Target Subcellular Location

    Nucleus.

  • Target Synonyms

    BABPB2 ; E4TF1 ; E4TF1 47 ; E4TF1 53; E4TF1B; GA binding protein beta chain; GA binding protein transcription factor beta subunit 2; GA-binding protein subunit beta-2; GABP 2; GABP subunit beta 1; GABP subunit beta 2; GABP subunit beta-2; GABP2_HUMAN; GABPB 1 ; GABPB-2; GABPB1 ; Gabpb2; NRF2B1 ; NRF2B2; Nuclear respiratory factor 2; Nuclear respiratory factor 2 subunit beta ; RP11-68I18.1; Transcription factor E4TF1 47; Transcription factor E4TF1 53

  • Target Background

    Enables transcription cis-regulatory region binding activity. Acts upstream of or within positive regulation of transcription by RNA polymerase II. Located in nucleus.

Inquire Recombinant Human GA-binding protein subunit beta-2 (GABPB2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification